Role of lidocaine patch 5 percent as analgesic in patient of post herpetic neuralgia
Phase 4
- Conditions
- Health Condition 1: B022- Zoster with other nervous system involvement
- Registration Number
- CTRI/2020/08/027262
- Lead Sponsor
- Department of Anesthesiology and Critical care Pt B D Sharma PGIMS Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with chronic pain having VAS score 4 for at least 3 month with no significant relief on conservative treatment
Exclusion Criteria
Any history of severe medical illness allergic to lidocaine pregnant and lactating female motor neuron disorders fever psychiatric disorders
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS Score before and after application of lidocaine patch at baseline 1 week 2 week 3 week 4 weekTimepoint: VAS Score before and after application of lidocaine patch at baseline 1 week 2 week 3 week 4 week
- Secondary Outcome Measures
Name Time Method Side effects if anyTimepoint: Before and Upto 4 weeks